Debjyoti Samanta

About Debjyoti Samanta

Debjyoti Samanta is currently pursuing an MBA degree at the University of Washington\'s Michael G.Foster School of Business, Class of \'26, with 5 years of prior experience in healthcare consulting. With a background in mechanical engineering, Debjyoti has specialized in healthcare consulting, particularly in the areas of advanced analytics and incentive compensation management. Throughout his tenure in management consulting, Debjyoti demonstrated profound capabilities in strategic project management, analytical problem-solving, and effective people management. His expertise in navigating complex analytics and leading diverse, cross-functional teams has driven significant operational efficiencies and business growth on a global scale. Debjyoti\'s strengths include a deep understanding of data-driven decision-making and an ability to translate intricate data insights into strategic business outcomes. His commitment to leadership is evident in his ability to foster team development and enhance client relationships, positioning him as a key player in high-stakes environments. Debjyoti is passionate about building professional relationships and is always open to discussing potential collaborations or sharing insights. Email ID - d•••••@uw.edu

Experience

1. Global Pipeline Strategy & Analytics Intern

   Merck

   Jun 2025 — Present · Rahway, NJ, US

   Led a cross-functional evaluation of an AI-driven insights platform to model the Ulcerative Colitis patient journey, aligning Medical, Marketing, & Data Science teams on 30+ strategic business questions to inform Merck’s GTM strategy for its first Immunology pipeline launch, targeting a $69B IBD market segment• Refined HCP segmentation logic for Merck’s IBD pipeline in collaboration with ZS, adding key model features—including patient load, comorbidity burden, and treatment behavior to identify the high-potential HCPs for Merck’s pipeline launch and enable creation of target customer list for the immunology field force • Led a process improvement initiative to create the first IBD playbook for Merck’s DDA team, consolidating 25+ fragmented inputs across 6 global stakeholders into a unified source of truth, resulting in estimated annual time savings of ~335 hours to support launch readiness for Merck’s first Immunology pipeline product

Education

• UW Foster School of Business

  Master of Business Administration - MBA

  2024 — 2026

• Indian Institute of Engineering Science and Technology (IIEST), Shibpur

  4 Year B.Tech

  2015 — 2019